• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MSP-RON信号通路在肝脏病理生物学中的作用及作为新兴治疗靶点的研究现状:现有证据综述

MSP-RON signaling in liver pathobiology and as an emerging therapeutic target: a review of the current evidence.

作者信息

Wu Kai, Ji Jia, Pan Jingying, Zhu Miaojin, Zhang Jiale, Sun Ting, Lv Dan, Wei Mudan, Wang Minghai, Yao Hangping

机构信息

State Key Laboratory for Diagnosis, Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China.

Jinan Microecological Biomedicine Shandong Laboratory, Jinan, 250000, China.

出版信息

Cell Commun Signal. 2025 Aug 28;23(1):385. doi: 10.1186/s12964-025-02407-5.

DOI:10.1186/s12964-025-02407-5
PMID:40877926
Abstract

The liver is a crucial organ in the human body and is responsible for various functions, including digestion, detoxification, metabolism, and immune response. Proper hepatic function is vital for maintaining systemic homeostasis, and dysregulation of liver signaling pathways contributes to various diseases. Recepteur d'Origine Nantais (RON) is a transmembrane receptor tyrosine kinase that is activated by macrophage-stimulating protein (MSP) and coordinates cell fate decisions through the activation of downstream signaling cascades. As the predominant source of MSP in humans, the liver establishes a liver-specific MSP‒RON autocrine‒paracrine signaling axis that contributes to hepatic regeneration, metabolism, and immune functions. Extensive research has demonstrated that MSP-RON signaling is involved in steatotic liver diseases, hepatitis, cirrhosis, cholestatic liver disease, and liver cancer, highlighting the importance of RON in the development of liver diseases. This review demonstrates the role of the MSP-RON pathway both in maintaining liver homeostasis and in driving disease onset and progression while exploring its signaling mechanisms and therapeutic potential for liver disorders.

摘要

肝脏是人体中的一个关键器官,负责多种功能,包括消化、解毒、代谢和免疫反应。正常的肝功能对于维持全身稳态至关重要,而肝脏信号通路的失调会导致各种疾病。南特起源受体(RON)是一种跨膜受体酪氨酸激酶,可被巨噬细胞刺激蛋白(MSP)激活,并通过激活下游信号级联反应来协调细胞命运决定。作为人类MSP的主要来源,肝脏建立了一个肝脏特异性的MSP-RON自分泌-旁分泌信号轴,该信号轴有助于肝脏再生、代谢和免疫功能。大量研究表明,MSP-RON信号传导参与脂肪性肝病、肝炎、肝硬化、胆汁淤积性肝病和肝癌,突出了RON在肝脏疾病发生发展中的重要性。本综述阐述了MSP-RON通路在维持肝脏稳态以及推动疾病发生和进展中的作用,同时探讨了其信号传导机制和对肝脏疾病的治疗潜力。

相似文献

1
MSP-RON signaling in liver pathobiology and as an emerging therapeutic target: a review of the current evidence.MSP-RON信号通路在肝脏病理生物学中的作用及作为新兴治疗靶点的研究现状:现有证据综述
Cell Commun Signal. 2025 Aug 28;23(1):385. doi: 10.1186/s12964-025-02407-5.
2
Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer.源自南特的受体(RON),不止是一种激酶:在去势抵抗性前列腺癌中的作用
Mol Carcinog. 2015 Oct;54(10):937-46. doi: 10.1002/mc.22354. Epub 2015 Jul 8.
3
Macrophage stimulating protein preserves blood brain barrier integrity after intracerebral hemorrhage through recepteur d'origine nantais dependent GAB1/Src/β-catenin pathway activation in a mouse model.巨噬细胞刺激蛋白通过在小鼠模型中激活受体源性南特依赖的 GAB1/Src/β-连环蛋白通路,在脑出血后保持血脑屏障的完整性。
J Neurochem. 2019 Jan;148(1):114-126. doi: 10.1111/jnc.14622. Epub 2018 Dec 5.
4
MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity.MSP-RON通路:炎症与固有免疫的潜在调节因子。
Front Immunol. 2020 Oct 7;11:569082. doi: 10.3389/fimmu.2020.569082. eCollection 2020.
5
The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer.MSP-RON 轴刺激三阴性乳腺癌模型中的癌细胞生长。
Mol Oncol. 2020 Aug;14(8):1868-1880. doi: 10.1002/1878-0261.12734. Epub 2020 Jun 17.
6
CircSRPK1 mediated by the exon junction complex promotes gastric cancer progression by interacting with hnRNP A2B1 to regulate RON mRNA alternative splicing.由外显子连接复合体介导的CircSRPK1通过与hnRNP A2B1相互作用调节RON mRNA可变剪接,从而促进胃癌进展。
Cancer Lett. 2025 Jun 16:217879. doi: 10.1016/j.canlet.2025.217879.
7
Structural basis for the binding specificity of human Recepteur d'Origine Nantais (RON) receptor tyrosine kinase to macrophage-stimulating protein.人源南特起源受体(RON)受体酪氨酸激酶与巨噬细胞刺激蛋白结合特异性的结构基础
J Biol Chem. 2014 Oct 24;289(43):29948-60. doi: 10.1074/jbc.M114.594341. Epub 2014 Sep 5.
8
RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer.RON 信号促进 ESR1 突变型乳腺癌的治疗抵抗。
Br J Cancer. 2021 Jan;124(1):191-206. doi: 10.1038/s41416-020-01174-z. Epub 2020 Dec 1.
9
Unlocking the potential of the ACE2/Ang-(1-7)/Mas Axis in liver diseases: From molecular mechanisms to translational applications.揭示ACE2/血管紧张素-(1-7)/Mas轴在肝脏疾病中的潜力:从分子机制到转化应用
Diabetes Obes Metab. 2025 Aug;27(8):4069-4082. doi: 10.1111/dom.16435. Epub 2025 May 9.
10
Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele.巨噬细胞刺激蛋白689C炎症性肠病风险等位基因的功能后果。
PLoS One. 2013 Dec 23;8(12):e83958. doi: 10.1371/journal.pone.0083958. eCollection 2013.

本文引用的文献

1
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3.肝星状细胞通过R-spondin 3控制肝脏的区域化、大小和功能。
Nature. 2025 Apr;640(8059):752-761. doi: 10.1038/s41586-025-08677-w. Epub 2025 Mar 12.
2
Steatotic liver disease.脂肪变性肝疾病。
Lancet. 2024 Nov 2;404(10464):1761-1778. doi: 10.1016/S0140-6736(24)01811-7.
3
Cabozantinib prevents the progression of metabolic dysfunction-associated steatohepatitis by inhibiting the activation of hepatic stellate cell and macrophage and attenuating angiogenic activity.
卡博替尼通过抑制肝星状细胞和巨噬细胞的激活以及减弱血管生成活性来预防代谢功能障碍相关脂肪性肝炎的进展。
Heliyon. 2024 Sep 27;10(19):e38647. doi: 10.1016/j.heliyon.2024.e38647. eCollection 2024 Oct 15.
4
Exceptional sustained long-term complete response to Tepotinib in a MET-amplified advanced intrahepatic biliary tract cancer failing Durvalumab plus Cisplatin and Gemcitabine.对于接受度伐利尤单抗联合顺铂和吉西他滨治疗失败的MET扩增晚期肝内胆管癌患者,特泊替尼展现出卓越的持续长期完全缓解。
Oncologist. 2024 Dec 6;29(12):1090-1094. doi: 10.1093/oncolo/oyae265.
5
Polymorphism rs3197999 in Pediatric Patients with Inflammatory Bowel Disease.小儿炎症性肠病患者 rs3197999 多态性。
Medicina (Kaunas). 2024 Jul 31;60(8):1243. doi: 10.3390/medicina60081243.
6
Therapeutic advances of targeting receptor tyrosine kinases in cancer.靶向治疗癌症受体酪氨酸激酶的治疗进展。
Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w.
7
Cabozantinib inhibits the growth of lenvatinib-resistant hepatoma cells restoring FTCD expression.卡博替尼抑制仑伐替尼耐药肝癌细胞的生长,恢复 FTCD 表达。
Biochem Pharmacol. 2024 Aug;226:116321. doi: 10.1016/j.bcp.2024.116321. Epub 2024 May 28.
8
Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor.梓醇通过抑制自然 RON 抑制剂抑制乳腺癌诱导的破骨细胞生成和骨溶解。
Phytomedicine. 2024 Jul;129:155688. doi: 10.1016/j.phymed.2024.155688. Epub 2024 Apr 28.
9
A phase Ib/II trial of capmatinib plus spartalizumab spartalizumab alone in patients with pretreated hepatocellular carcinoma.一项卡马替尼联合斯巴鲁单抗与单独使用斯巴鲁单抗治疗经治肝细胞癌患者的 Ib/II 期试验。
JHEP Rep. 2024 Jan 28;6(4):101021. doi: 10.1016/j.jhepr.2024.101021. eCollection 2024 Apr.
10
Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations.一项研究吉立替尼(MGCD265)治疗含 MET 激活改变的晚期 NSCLC 患者的疗效和安全性的 II 期研究。
Lung Cancer. 2024 Apr;190:107512. doi: 10.1016/j.lungcan.2024.107512. Epub 2024 Feb 22.